Arrivent Biopharma Inc (AVBP)

Investing Cash Flow

-$72.31M

TTM · Period ending: · USD

AVBP logo

AVBP Investing Cash Flow

Latest reported-$72.31M
AVBP TTM Cash from Investing (-$25.00M → -$72.31M)
High-resolution chart · PNG

AVBP investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arrivent Biopharma Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-72,305,000
-104,467,000
-71,228,000
-192,494,000
-141,734,000
-155,644,000
-192,465,000
25,000,000
25,000,000
0
0
-25,000,000
-25,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.